Company Overview of Piper Jaffray & Co.
Piper Jaffray & Co. is a boutique investment banking and institutional securities firm that caters to middle market companies. It provides equity, debt, and convertible underwriting; private placement; financial restructuring; and mergers and acquisitions advisory services. Additionally, the firm offers private investment in public equity and registered direct, block trading of restricted stock, cash management, and venture capital support services. It caters to alternative energy, business services, consumer, financial institutions, healthcare, industrial growth, and technology sectors. The firm is based in Minneapolis, Minnesota. Piper Jaffray & Co. operates as a subsidiary of Piper Jaffra...
800 Nicollet Mall
Minneapolis, MN 55402-7020
Key Executives for Piper Jaffray & Co.
Chairman and Chief Executive Officer
Head of Investment Research & Fixed Income Research and Managing Director
Managing Director of Investment Banking - Public Finance Services
Compensation as of Fiscal Year 2016.
Piper Jaffray & Co. Key Developments
Piper Jaffray & Co. Presents at Medtech Conference, Jun-01-2016 01:30 PM
May 30 16
Piper Jaffray & Co. Presents at Medtech Conference, Jun-01-2016 01:30 PM. Venue: Loews Minneapolis Hotel, 601 1st Ave N, Minneapolis, MN 55403, United States. Speakers: J P Peltier, Global Head, Healthcare Investment Banking.
Six Firms to Pay $103.5 Million in Preliminary Settlements over Bid-Rigging
Feb 24 16
Six broker-dealers and investment providers have agreed to pay $103.35 million in preliminary settlements of charges by issuers and state attorneys general that they engaged in bid-rigging and price fixing for municipal investment products and derivatives. The proposed money to be paid is a result of a coordinated effort by 22 attorneys general along with the city of Baltimore and the Central Bucks School District in Pennsylvania, which are leaders of a class action suit with numerous issuers. The litigation has been ongoing since about 2008. About $100.5 million of the preliminary settlement amounts come from the issuer class action litigation and includes all six firms. The rest comes from preliminary settlements with the attorneys general and only concerns two firms, New York-based Natixis Funding Corp. and French multinational company Societe Generale. Of the six proposed settlements, UBS AG agreed to pay the most -- $32 million in the class action litigation. Natixis and Societe Generale agreed to pay about $30 million and $26.75 million, respectively, with $28.45 million and $25.41 million of those amounts, resulting from the class action litigation. The remaining three firms involved in only the class action litigation are Minneapolis-based Piper Jaffray & Co., which would pay $9.75 million, London-based National Westminster Bank, which would pay $3.5 million, and Kansas City, Mo-based George K. Baum & Co., which would pay $1.4 million. The proposed class action settlements are subject to preliminary approval by Judge Victor Marrero, who sits on the U. S. District Court for the Southern District of New York in Manhattan. The documents will then be circulated among the issuers in the class action suit to gather their comments. If, after receiving comments from the class participants, Marrero gives final approval to the six settlements, it will bring an end to more than eight years of litigation that began when a large number of issuers filed actions that were then consolidated with several lead plaintiffs in the New York district court.
Piper Jaffray & Co. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 08:00 AM
Dec 8 15
Piper Jaffray & Co. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 08:00 AM. Venue: Parc 55 San Francisco, 55 Cyril Magnin Street, San Francisco, CA 94102, United States. Speakers: Charles Duncan, Biotechnology Analyst.
Similar Private Companies By Industry
Recent Private Companies Transactions